India bolsters regulators to brace global competition
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister.
Drugs
Pharma
Drugs
Pharma
Glenmark’s heart failure treatment drug makes India debut
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs
Pharma
US regulatory nod for Lupin’s HIV drug in the works
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat.
Drugs
Pharma
USFDA grants ‘tentative approval’ to Zydus’ mental health drug
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Health
Pharma
Uncategorized
Domestic formulations to aid pharma growth: ICICI Direct
The Indian pharmaceutical industry is expected to witness “decent growth” during the three-month period through 31 March 2023, mainly led by continued traction.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
Drugs
Medical
Pharma
UK’s AI stroke machine to cut treatment time by 60 mts
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up clinicians’ time.
Drugs
Pharma
WHO issues medical product alert on Marion’s syrups
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality.